Myriad Genetics, Inc. Share Price
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.31 USD | +2.89% | -0.63% | +32.24% |
13/05 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2024 * | 83Cr 6.92TCr | Sales 2025 * | 90Cr 7.46TCr | Capitalization | 228.89Cr 19TCr |
---|---|---|---|---|---|
Net income 2024 * | -9.2Cr -765.99Cr | Net income 2025 * | -6.4Cr -532.86Cr | EV / Sales 2024 * | 2.64 x |
Net cash position 2024 * | 9.39Cr 782.09Cr | Net cash position 2025 * | 12Cr 968.61Cr | EV / Sales 2025 * | 2.42 x |
P/E ratio 2024 * |
-27
x | P/E ratio 2025 * |
-36.1
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.91% |
Latest transcript on Myriad Genetics, Inc.
1 day | +2.89% | ||
1 week | -0.63% | ||
Current month | +29.33% | ||
1 month | +36.81% | ||
3 months | +8.86% | ||
6 months | +41.63% | ||
Current year | +32.24% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 13/20/13 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | 29/01 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 16/09/16 |
Paul Bisaro
BRD | Director/Board Member | 63 | 31/22/31 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 27/20/27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 14 M€ | -2.98% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 25.29 | +2.76% | 598,558 |
16/24/16 | 24.61 | -0.20% | 899,188 |
15/24/15 | 24.66 | -2.76% | 1,410,760 |
14/24/14 | 25.36 | +1.72% | 1,307,022 |
13/24/13 | 24.93 | -2.12% | 1,205,413 |
Delayed Quote Nasdaq, May 18, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.24% | 228.89Cr | |
-4.52% | 1.23TCr | |
-5.19% | 806.62Cr | |
+8.38% | 591.18Cr | |
+28.50% | 552.21Cr | |
-8.09% | 421.2Cr | |
+13.49% | 273.28Cr | |
-2.05% | 242.91Cr | |
-3.55% | 188.74Cr | |
+3.02% | 159.94Cr |
- Stock Market
- Equities
- MYGN Stock